Patent · US Expired

Chrolactomycin compound

US5965604A · kind A · utility

1Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 1998
Grant dateOct 12, 1999
Priority date
Expiry dateDec 17, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/886
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to chrolactomycin compound represented by the following formula (I): ##STR1## or pharmaceutically acceptable salts thereof having antibacterial and antitumor activities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.